Lucid Group reaches the finals of the PM360 2020 Trailblazer Initiative Awards
Aug 19, 2020
Lucid Group Company has been named as a finalist in the PM360 2020 Trailblazer Initiative Awards in the HCP Education category, for the program LiBRA 2019: Looking beyond the joint in rheumatoid arthritis (RA): Is there a missing link in RA management?
LiBRA is a multichannel program, focused on inspiring and enabling clinical behavior change to achieve better disease control for patients with RA. By providing multiple touchpoints across different channels such as active MSL follow-up and an accompanying publication, it provided an enhanced and extended learning journey for delegates ― driving a change in behavior which ultimately enhances patient outcomes.
Lisa Druce, Managing Director, Lighthouse Medical Communications US, commented “RA is a chronic disease affecting around 1% of the world’s population. We’re very happy to be able to further raise awareness of this important program. It’s a program Lucid Group is tremendously proud to be part of – transforming patients’ lives across the world. We’re looking forward to the virtual celebrations on Oct 1st.”
Since 2009, the PM360 Trailblazer awards have recognized outstanding achievement and innovation in healthcare marketing. Each year, nominations are judged by the PM360 Editorial Advisory Board, a distinguished cross-section of industry experts. Winning initiatives were selected for their ability to stand out in the complex, ever-changing healthcare environment, and were judged on their ability to overcome challenges; the skill, innovation, and quality of planning and execution; and the effectiveness of the work.
“The very best marketing initiatives are defined by their ability to stand out, and these 82 finalists made an impression on our judges for their ability to do just that,” says Anna Stashower, CEO and Publisher of PM360. “While some stood out thanks to their eye-catching creative, others left judges in awe due to a unique ability to educate patients or doctors, an empathic approach that took judges into the bodies and souls of patients, an innovative use of technology to connect with patients in new ways or make it easier for them to get life-saving treatments, or just a fascinating new strategy that can change how the rest of the industry operates.”
- The Lucid Group Wellbeing Champions embark on their MHFA training
- Lucid Group reaches the finals of the PM360 2020 Trailblazer Initiative Awards
- Emma is celebrating ten magical years at Lucid Group
- Lucid Group scoop a win and a high commendation at Communiqué 2020
- PHARMA POST COVID-19: REVOLUTION OR EVOLUTION?